Neurones (France) Performance
| NRO Stock | EUR 45.75 0.35 0.77% |
Neurones has a performance score of 5 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.2, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Neurones' returns are expected to increase less than the market. However, during the bear market, the loss of holding Neurones is expected to be smaller as well. Neurones right now secures a risk of 1.0%. Please verify Neurones value at risk, kurtosis, market facilitation index, as well as the relationship between the semi variance and rate of daily change , to decide if Neurones will be following its current price movements.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Neurones are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Neurones is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 266.5 M | |
| Total Cashflows From Investing Activities | -10.6 M |
Neurones |
Neurones Relative Risk vs. Return Landscape
If you would invest 4,380 in Neurones on August 28, 2024 and sell it today you would earn a total of 195.00 from holding Neurones or generate 4.45% return on investment over 90 days. Neurones is generating 0.0719% of daily returns assuming 0.9976% volatility of returns over the 90 days investment horizon. Simply put, 8% of all stocks have less volatile historical return distribution than Neurones, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Neurones Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neurones' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Neurones, and traders can use it to determine the average amount a Neurones' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0721
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | NRO | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.0 actual daily | 8 92% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Neurones is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neurones by adding it to a well-diversified portfolio.
Neurones Fundamentals Growth
Neurones Stock prices reflect investors' perceptions of the future prospects and financial health of Neurones, and Neurones fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Neurones Stock performance.
| Return On Equity | 0.14 | |||
| Return On Asset | 0.077 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 735.59 M | |||
| Shares Outstanding | 24.22 M | |||
| Price To Earning | 21.03 X | |||
| Price To Book | 3.01 X | |||
| Price To Sales | 1.50 X | |||
| Revenue | 579.88 M | |||
| EBITDA | 72.17 M | |||
| Cash And Equivalents | 169.6 M | |||
| Cash Per Share | 7.20 X | |||
| Total Debt | 27.82 M | |||
| Debt To Equity | 0.10 % | |||
| Book Value Per Share | 12.78 X | |||
| Cash Flow From Operations | 64.5 M | |||
| Earnings Per Share | 1.71 X | |||
| Total Asset | 567.82 M | |||
| Retained Earnings | 21 M | |||
| Current Asset | 284 M | |||
| Current Liabilities | 133 M | |||
About Neurones Performance
By analyzing Neurones' fundamental ratios, stakeholders can gain valuable insights into Neurones' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Neurones has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Neurones has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Neurones S.A., an information technology services company, provides infrastructure, application, and consulting services in France and internationally. Neurones S.A. was founded in 1985 and is headquartered in Nanterre, France. NEURONES operates under Information Technology Services classification in France and is traded on Paris Stock Exchange. It employs 5160 people.Things to note about Neurones performance evaluation
Checking the ongoing alerts about Neurones for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Neurones help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 71.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Neurones' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Neurones' stock is overvalued or undervalued compared to its peers.
- Examining Neurones' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Neurones' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Neurones' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Neurones' stock. These opinions can provide insight into Neurones' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Neurones Stock analysis
When running Neurones' price analysis, check to measure Neurones' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurones is operating at the current time. Most of Neurones' value examination focuses on studying past and present price action to predict the probability of Neurones' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurones' price. Additionally, you may evaluate how the addition of Neurones to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |